Loading
Every trade that managers of Highnoon Laboratories Limited disclose to PSX (SECP) is tracked on this page. In the past year (19 October 2025 to 19 October 2026), 3 filings came from 0 insiders.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
With 3 filings in twelve months, the company is in line with the median of 3 filings across the 283 companies we follow on the same exchange.
No insider has bought Highnoon Laboratories Limited shares on the open market in the past twelve months.
These figures are compiled from regulatory filings published by PSX (SECP). They describe what insiders did and are not a recommendation.
· cache
21 of 21 declarations
Highnoon Laboratories Limited is a pharmaceutical company based in Pakistan, specializing in the research, development, and manufacturing of pharmaceutical products. It is listed on the XKAR market.